<![CDATA[Addressing Prospective Data Gaps for Radiotherapy Use in Multiple Myeloma]]>

ConferenceNeutral

AI Analysis

Summary

Alexandra Dreyfuss, MD, MS, discusses why patients treated with CAR T-cell therapy and bispecific antibodies are her priority populations for prospective radiotherapy studies in multiple myeloma, addressing existing data gaps.

Importance:2/10

Sentiment:

0.00

multiple myelomaradiotherapyCAR Tbispecific antibodiesprospective studiesexpert interview

Read the original article

Published by Cancer Network on October 16, 2026 8:00 PM

Read Original